NCT03099694

Brief Summary

The investigators compared advantages and disadvantages of two forms of noninvasive respiratory support -noninvasive high-frequency oscillatory ventilation (nHFOV) or nasal continuous positive airway pressure (nCPAP) -as a primary mode of ventilation in premature infants with RDS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
340

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2016

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 4, 2017

Completed
23 days until next milestone

Study Start

First participant enrolled

April 27, 2017

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2018

Completed
11 months until next milestone

Results Posted

Study results publicly available

June 10, 2019

Completed
Last Updated

March 2, 2021

Status Verified

February 1, 2021

Enrollment Period

1.3 years

First QC Date

November 17, 2016

Results QC Date

October 7, 2018

Last Update Submit

February 8, 2021

Conditions

Keywords

NRDSnHFOVnCPAPpreterm infants

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Required Intubation

    The criteria for endotracheal mechanical ventilation were as follows: severe respiratory acidosis (PaCO2 \> 60 mmHg with pH\<7.20), severe apnea and bradycardia (defined as recurrent apnea with \> 3 episodes per hour associated with heart rate \< 100/min, a single episode of apnea that required bag and mask ventilation), hypoxia (FiO2\>0.5 with PaO2\<50mmHg), severe respiratory distress, neonatal pulmonary hemorrhage, and cardiopulmonary arrest without effective resuscitation needing continued ventilation and rescue

    during the first 7 days after birth

Secondary Outcomes (12)

  • the Incidence of Intraventricular Hemorrhage (IVH, ≥ Grade Ⅲ)

    first two months after birth

  • the Incidence of Pneumothorax

    during non-invasive ventilation, up to 7 days

  • the Incidence of Neonatal Necrotizing Enterocolitis(>Stage II)

    during non-invasive ventilation, up to 7 days

  • the Incidence of Retinopathy of Prematurity (>Stage II)

    at a post-menstrual age of 36 weeks or at discharge

  • The Score of Bayley Scales of Infant Development

    30 months

  • +7 more secondary outcomes

Study Arms (2)

nCPAP

ACTIVE COMPARATOR

nasal continuous positive airway pressure (nCPAP) - as a primary mode of ventilation in premature infants with RDS

Procedure: nasal continuous positive airway pressure (nCPAP)

nHFOV

EXPERIMENTAL

noninvasive high-frequency ventilation (nHFOV) as a primary mode of ventilation in premature infants with RDS

Procedure: noninvasive high-frequency ventilation (nHFOV)

Interventions

NHFOV will be provided by a high frequency ventilator (CNO, Medin, Germany or SLE 5000, UK). NHFOV will be provided via binasal prongs.

nHFOV

Infants assigned to the NCPAP group will be started on a pressure of 6 cmH2O (range: 6-8 cmH2O) by CPAP system (CNO Medin, Germany, Carefusion, USA)

nCPAP

Eligibility Criteria

AgeUp to 12 Hours
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • (1)Gestational age (GA) is from 26 to 34 weeks; (2) diagnosis of RDS. The diagnosis of RDS will be based on clinical manifestations (tachypnea, nasal flaring and or grunting) and chest X-ray findings; (3) RDS Silverman score\>5; (4) informed parental consent has been obtained.

You may not qualify if:

  • (1) severe RDS requiring early intubation according to the American Academy of Pediatrics guidelines for neonatal resuscitation7; (2)major congenital malformations or complex congenital heart disease; (3) group B hemolytic streptococcus pneumonia, septicemia, pneumothorax, pulmonary hemorrhage; (4) cardiopulmonary arrest needing prolonged resuscitation; (5) transferred out of the NICUs without treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xingwang Zhu

Chongqing, Chongqing Municipality, 400000, China

Location

Related Publications (2)

  • Zhu X, Feng Z, Liu C, Shi L, Shi Y, Ramanathan R; NHFOV study group. Nasal High-Frequency Oscillatory Ventilation in Preterm Infants with Moderate Respiratory Distress Syndrome: A Multicenter Randomized Clinical Trial. Neonatology. 2021;118(3):325-331. doi: 10.1159/000515226. Epub 2021 Apr 7.

  • Zhu XW, Shi Y, Shi LP, Liu L, Xue J, Ramanathan R; NHFOV Study Group. Non-invasive high-frequency oscillatory ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: Study protocol for a multi-center prospective randomized controlled trial. Trials. 2018 Jun 14;19(1):319. doi: 10.1186/s13063-018-2673-9.

MeSH Terms

Interventions

Continuous Positive Airway Pressure

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Results Point of Contact

Title
Prof. Shi Yuan
Organization
Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing

Study Officials

  • Shi Yuan, PhD

    Third Military Medical University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Director of neonatology

Study Record Dates

First Submitted

November 17, 2016

First Posted

April 4, 2017

Study Start

April 27, 2017

Primary Completion

July 28, 2018

Study Completion

July 28, 2018

Last Updated

March 2, 2021

Results First Posted

June 10, 2019

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

Dr. Kris Sekar, Professor of Pediatrics, Oklahoma University Medical Center, Oklahoma, Dr. Jatinder Bhatia, Professor of Pediatrics, Medical College of Georgia, Georgia Health Sciences University, Augusta, Georgia, and Dr. Rowena Cayabyab, MD., MPH (Biostatistics and Epidemiology) Assistant Professor of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California will serve as DSMB members. Dr. Cayabyab will also serve as consultant for statistical analysis.

Locations